Research Topics
Species | Luc ThomasSummaryAffiliation: Hospices Civils de Lyon Country: France Publications
| Collaborators
|
Detail Information
Publications
Dermoscopy provides useful information for the management of melanonychia striataLuc Thomas
Service de Dermatologie, Université Lyon France and Hôtel Dieu de Lyon, Lyon Cedex France
Dermatol Ther 20:3-10. 2007....
Oral calcitriol: a new therapeutic agent in cutaneous lichen sclerosisS Ronger
Department of Dermatology, Hotel Dieu Hospital, 1 Place de l Hopital, 69288 Lyon, France
J Drugs Dermatol 2:23-8. 2003..Because of the success of calcitriol in localized scleroderma, we attempted this therapy in a patient with LS...
[Pathology of the eyelid in elderly patients]L Thomas
Service de Dermatologie, Hotel Dieu, Lyon
J Fr Ophtalmol 29:672-86. 2006..Didactic review of the various features of eyelid pathology in elderly patients...
Sarcoidosis and melanoma: a referral center study of 1,199 casesPascal Seve
Department of Internal Medicine, Hospices Civils de Lyon, Universite Lyon 1, Lyon, France
Dermatology 219:25-31. 2009..Case reports and small short case series have described patients with sarcoidosis and melanoma...
Skin cancers arising in tattoos: coincidental or not?Nicolas Kluger
Department of Dermatology, University of Montpellier I, Hopital Saint Eloi, CHU Montpellier, Montpellier, France
Dermatology 217:219-21. 2008..We report here 2 new cases and wish to discuss the arguments and counter-arguments for such a potential relationship...
Targeted therapies in metastatic melanoma: toward a clinical breakthrough?Fanny Julia
Centre de Recherche en Cancérologie de Lyon, Faculte de Medecine Rockefeller, 8 avenue Rockefeller, 69008 Lyon, France
Anticancer Agents Med Chem 10:661-5. 2010..These recently published data shed the light on melanoma management. We review here the latest development of these molecules and the current perspectives in the treatment of metastatic melanoma...
A phase II trial of miltefosine in patients with cutaneous T-cell lymphomaCharles Dumontet
Service d Hematologie, CH Lyon Sud, Pierre Benite, Laboratoire d Hematologie, Pavillon E, Hopital Edouard Herriot, 5 Place d Arsonval, 69003 Lyon Cedex 03, France
Bull Cancer 93:E115-8. 2006..The overall response rate was 58 % with a median duration of response of 12 months. Miltefosine is a safe, simple and effective treatment in certain patients with cutaneous T-cell lymphoma...
Scabies with clinical features and positive darier sign mimicking mastocytosisAlice Phan
Department of Dermatology, Hotel Dieu Hospital, Claude Bernard University Lyon, Cedex France
Pediatr Dermatol 26:363-4. 2009..We report a misleading case of a 5-month-old child, who presented with pruritic brown-red macules of the trunk showing a positive Darier's sign, suggestive of an urticaria pigmentosa...
Primary cutaneous marginal zone lymphomaStephane Dalle
Service de Dermatologie, Universite Claude Bernard Lyon I, Hospices Civils de Lyon, Lyon, France
Crit Rev Oncol Hematol 74:156-62. 2010..If local therapies (surgery, radiation) are the gold standard for localized disease, rituximab can also be considered as an alternative for disseminated or plurifocal PCMZL...
Scleromyxedema: successful treatment with thalidomide in two patientsMona Amini Adle
Department of Dermatology, hôpital de l Hôtel dieu, Lyon, France
Dermatology 214:58-60. 2007..Scleromyxedema is an unusual skin disease characterized by mucinous infiltration of the skin. There is no satisfactory treatment for this disorder...
Primary cutaneous marginal zone lymphoma as a complication of radiation therapy: Case report and reviewAnne Laure Breton
Service de Dermatologie, Centre Hospitalier Lyon Sud, Pierre Benite, France
Dermatol Online J 16:6. 2010..The occurrence of primary cutaneous B-cell lymphoma at the site of radiation therapy is exceptional. We report herein the case of a primary cutaneous marginal zone lymphoma arising at the site of radiotherapy for breast cancer...
Aggressive CD30 large cell lymphoma after cyclosporine given for putative atopic dermatitisFanny Mougel
Service de Dermatologie, , Lyon, France
Dermatology 213:239-41. 2006..It stresses the fact that skin biopsies should be taken in case of atypical AD to rule out MF and avoid such an aggressive evolution under immunosuppressive therapy...
How pharmacogenomics of biological response modifiers will influence clinical response and toxicity in dermatologyStephane Dalle
Service de Dermatologie, Universite Claude Bernard Lyon I, Hospices Civils de Lyon, Lyon, France
Int J Dermatol 50:114-8. 2011..We review the current data focusing on the BRMs widely used in the practice of dermatology...
[Genotypic hypervariability of melanoma: a therapeutic challenge]Stephane Dalle
Service de Dermatologie, hôpital de l Hôtel dieu, Lyon, France
Med Sci (Paris) 22:178-82. 2006..It is hope that this better understanding of the biologic features of melanoma and the mechanisms underlying tumor-induced immunosuppression will lead to efficaceous targeted therapy...
Coexisting pseudoxanthoma elasticum and lupus erythematosus: report of two casesJulie Le Scanff
Department of Internal Medicine, Hotel Dieu, Lyon, France
Int J Dermatol 46:622-4. 2007..Given the ocular and vascular complications of PXE, clinicians who treat patients with lupus should be aware of this possible association...
Pediatric mastocytosis is a clonal disease associated with D816V and other activating c-KIT mutationsChristine Bodemer
Service de Dermatologie, Hopital Necker, CEREMAST, centre de référence des mastocytoses, Faculte Necker, Universite Rene Descartes Paris V, Paris, France
J Invest Dermatol 130:804-15. 2010..These findings strongly support the idea that, although pediatric mastocytosis can spontaneously regress, it is a clonal disease most commonly associated with activating mutations in c-KIT...
Comparative study of stress and quality of life in outpatients consulting for different dermatoses in 5 academic departments of dermatologyLaurent Misery
Service de Dermatologie, CHU Brest, Brest, France
Eur J Dermatol 18:412-5. 2008..On the contrary, patients with psoriasis had a very high level of perceived stress and a deeply altered quality of life...
Lymphomatoid papulosis localized to the faceStephane Dalle
Service de Dermatologie, hôpital de l Hôtel dieu, 1 Place de l Hopital, 69288 Lyon Cedex 02
Dermatol Online J 12:9. 2006..This is the first reported case of LyP localized to the face...
Ungueotropic T-cell lymphomaElise Harland
Arch Dermatol 142:1071-3. 2006
Diagnosis and management of nail pigmentationsRalph Peter Braun
Pigmented Skin Lesion Unit, Department of Dermatology, University Hospital Geneva, Switzerland
J Am Acad Dermatol 56:835-47. 2007..In this article, we will review the management, including diagnosis as well as differential diagnosis of nail pigmentations and propose a new algorithm for the non invasive diagnosis of nail pigmentation...
Dermoscopic examination of nail pigmentationSandra Ronger
Dermatology Unit, , 69288 Lyon Cedex 02, France
Arch Dermatol 138:1327-33. 2002....
Dermoscopic evaluation of amelanotic and hypomelanotic melanomaScott W Menzies
Faculty of Medicine, University of Sydney, Sydney Melanoma Diagnostic Centre, Royal Prince Alfred Hospital, Camperdown, NSW 2050, Australia
Arch Dermatol 144:1120-7. 2008..To determine the predictive dermoscopic features of amelanotic and hypomelanotic melanoma...
The dragon with atypical mole syndromeNicolas Kluger
Arch Dermatol 144:948-9. 2008
Time required for a complete skin examination with and without dermoscopy: a prospective, randomized multicenter studyIris Zalaudek
Department of Dermatology, Medical University of Graz, Auenbruggerplatz 8, 8036 Graz, Austria
Arch Dermatol 144:509-13. 2008..To determine the time required to perform a complete skin examination (CSE) as a means of opportunistic screening for skin cancer both without and with dermoscopy...
New founder germline mutations of CDKN2A in melanoma-prone families and multiple primary melanoma development in a patient receiving levodopa treatmentCaroline Kannengiesser
Service de Genetique, Institut Gustave Roussy, Villejuif, France
Genes Chromosomes Cancer 46:751-60. 2007..This observation suggests that there is a need for reconsideration of the hypothesis that levodopa may play a role in melanoma development, at least when in the context of a high-risk genetic background...
[Epithelial and melanic skin tumors]Luc Thomas
, , , INSERM U 346, 69288 Lyon
Rev Prat 52:797-806. 2002
Subungual blue nevusAnne Sophie Causeret
Dermatology Unit, , France
J Am Acad Dermatol 49:310-2. 2003..Blue nevus has been very rarely reported in this location. We report the second clinicopathologic study of a subungual blue nevus...
The contribution of large genomic deletions at the CDKN2A locus to the burden of familial melanomaF Lesueur
Groupe Mélanome, Institut Gustave Roussy, FRE2939 CNRS Université Paris Sud, Villejuif, France
Br J Cancer 99:364-70. 2008..1% of total mutations in this series (1 of 48), confirming that they explain a very small proportion of CMM susceptibility. In addition, we excluded a new gene on 9p21, KLHL9, as being a major CMM gene...
Purification and structural characterization of de-N-acetylated form of GD3 ganglioside present in human melanoma tumorsIuliana Popa
Laboratory of Dermatological Research, University of Lyon 1 and Edouard Herriot Hospital, 69437 Lyon cx 03, France
Glycobiology 17:367-73. 2007....
mda-9/Syntenin: a positive regulator of melanoma metastasisHabib Boukerche
Department of Pathology, Columbia University Medical Center, College of Physicians and Surgeons, New York, New York 10032, USA
Cancer Res 65:10901-11. 2005..Based on its ability to directly alter metastasis, mda-9/syntenin provides a promising new focus for melanoma cancer research with potential therapeutic applications for metastatic diseases...
Surgical Pearl: Dermoscopy of the free edge of the nail to determine the level of nail plate pigmentation and the location of its probable origin in the proximal or distal nail matrixRalph P Braun
Pigmented Skin Lesion Unit, Department of Dermatology, University Hospital Geneva, Geneva, Switzerland
J Am Acad Dermatol 55:512-3. 2006
